Galmed Pharmaceuticals: 3Q Earnings Snapshot

November 6, 2019 GMT

TEL AVIV, Israel (AP) _ Galmed Pharmaceuticals Ltd. (GLMD) on Wednesday reported a loss of $4.5 million in its third quarter.

The Tel Aviv, Israel-based company said it had a loss of 21 cents per share.

The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 32 cents per share.

The company’s shares closed at $4.75. A year ago, they were trading at $11.38.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on GLMD at https://www.zacks.com/ap/GLMD